{"data":[{"accessionNo":"0001716774-26-000028","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-09-30","reportingPerson":"Aberdeen Group plc","reportingCik":null,"personType":"HC","sharesOwned":1090427,"percentOfClass":7.99,"filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001716774-26-000028","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-09-30","reportingPerson":"abrdn Inc.","reportingCik":null,"personType":"CO,IA","sharesOwned":1090427,"percentOfClass":7.99,"filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001831942-26-000038","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-06-30","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1511821,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001831942-26-000038","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-06-30","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"HC,IN","sharesOwned":1511821,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001831942-26-000038","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-06-30","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":1511821,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001831942-26-000038","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-06-30","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":1511821,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-097293","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":1079843,"percentOfClass":7.47,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-097293","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":1079843,"percentOfClass":7.47,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-097293","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":1079843,"percentOfClass":7.47,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000947871-26-000800","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"OrbiMed Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":756860,"percentOfClass":5.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000947871-26-000800","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"OrbiMed Genesis GP LLC","reportingCik":null,"personType":"OO","sharesOwned":756860,"percentOfClass":5.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000947871-26-000800","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"OrbiMed Capital LLC","reportingCik":null,"personType":"IA","sharesOwned":388540,"percentOfClass":2.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-088748","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Soleus Capital Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":679200,"percentOfClass":4.9,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-088748","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Soleus GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":679200,"percentOfClass":4.9,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-088748","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Guy Levy","reportingCik":null,"personType":"IN","sharesOwned":679200,"percentOfClass":4.9,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-088748","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Soleus Capital Master Fund, L.P.","reportingCik":null,"personType":"FI","sharesOwned":679200,"percentOfClass":4.9,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-088748","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Soleus Capital, LLC","reportingCik":null,"personType":"OO","sharesOwned":679200,"percentOfClass":4.9,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-088748","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Soleus Capital Group, LLC","reportingCik":null,"personType":"OO","sharesOwned":679200,"percentOfClass":4.9,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-092235","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":969547,"percentOfClass":7,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-092235","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":969547,"percentOfClass":7,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-092235","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":969547,"percentOfClass":7,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-092235","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":960816,"percentOfClass":6.9,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001390202-26-000013","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Benjamin Alexander Smith","reportingCik":null,"personType":"HC,IN","sharesOwned":839526,"percentOfClass":6.06,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001390202-26-000013","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Janaka Sheehan Maduraperuma","reportingCik":null,"personType":"HC,IN","sharesOwned":839526,"percentOfClass":6.06,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001390202-26-000013","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Laurion Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":839526,"percentOfClass":6.06,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001716774-26-000017","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-06-30","reportingPerson":"Aberdeen Group plc","reportingCik":null,"personType":"HC","sharesOwned":824393,"percentOfClass":6.05,"filedAt":"2026-07-16","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001716774-26-000017","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-06-30","reportingPerson":"abrdn Inc.","reportingCik":null,"personType":"CO,IA","sharesOwned":824393,"percentOfClass":6.05,"filedAt":"2026-07-16","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-26-002364","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Anand Parekh","reportingCik":null,"personType":"IN","sharesOwned":6332000,"percentOfClass":4.85,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-26-002364","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Alyeska Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":6332000,"percentOfClass":4.85,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-26-002364","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Alyeska Investment Group, L.P.","reportingCik":null,"personType":"IA","sharesOwned":6332000,"percentOfClass":4.85,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-001364","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Zweiman Ari","reportingCik":null,"personType":"IN","sharesOwned":474200,"percentOfClass":3.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-001364","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"683 CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":474200,"percentOfClass":3.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-001364","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"683 CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"IA","sharesOwned":474200,"percentOfClass":3.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-056411","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-29","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":793621,"percentOfClass":5.7,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-056411","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-29","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":793621,"percentOfClass":5.7,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-056411","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-29","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":793621,"percentOfClass":5.7,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-056411","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-29","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":743281,"percentOfClass":5.4,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-26-002262","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-17","reportingPerson":"Avidity Private Master Fund I LP","reportingCik":null,"personType":"PN","sharesOwned":13958410,"percentOfClass":9.9,"filedAt":"2026-04-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-26-002262","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-17","reportingPerson":"Avidity Partners Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":13958410,"percentOfClass":9.9,"filedAt":"2026-04-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-26-002262","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-17","reportingPerson":"Avidity Partners Management (GP) LLC","reportingCik":null,"personType":"OO","sharesOwned":13958410,"percentOfClass":9.9,"filedAt":"2026-04-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-26-002262","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-17","reportingPerson":"Avidity Capital Partners Fund (GP) LP","reportingCik":null,"personType":"PN","sharesOwned":13958410,"percentOfClass":9.9,"filedAt":"2026-04-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-26-002262","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-17","reportingPerson":"Avidity Capital Partners (GP) LLC","reportingCik":null,"personType":"OO","sharesOwned":13958410,"percentOfClass":9.9,"filedAt":"2026-04-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-26-002262","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":"4525EP101","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-17","reportingPerson":"Michael Gregory","reportingCik":null,"personType":"HC,IN","sharesOwned":13958410,"percentOfClass":9.9,"filedAt":"2026-04-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-26-001332","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-17","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":11454000,"percentOfClass":8.69,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-26-001332","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-17","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":11454000,"percentOfClass":8.69,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-26-001332","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-17","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":8953630,"percentOfClass":6.79,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-26-001332","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-17","reportingPerson":"Deep Track Special Opportunities Fund, LP.","reportingCik":null,"personType":"PN","sharesOwned":2500370,"percentOfClass":1.9,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001831942-26-000012","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001","eventDate":"2026-02-17","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"HC,IN","sharesOwned":13350121,"percentOfClass":9.9,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001831942-26-000012","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001","eventDate":"2026-02-17","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":13350121,"percentOfClass":9.9,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001831942-26-000012","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001","eventDate":"2026-02-17","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":13350121,"percentOfClass":9.9,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001831942-26-000012","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001","eventDate":"2026-02-17","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":13350121,"percentOfClass":9.9,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001493152-26-007882","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-17","reportingPerson":"Trails Edge Capital Partners, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":11454000,"percentOfClass":8.7,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001493152-26-007882","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-17","reportingPerson":"Ortav Yehudai","reportingCik":null,"personType":"IN","sharesOwned":11454000,"percentOfClass":8.7,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001493152-26-007882","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-17","reportingPerson":"Trails Edge Biotechnology Master Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":11454000,"percentOfClass":8.7,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-018848","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Vivo Opportunity Cayman Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2942094,"percentOfClass":9.99,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-018848","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Vivo Opportunity, LLC","reportingCik":null,"personType":"OO","sharesOwned":29126906,"percentOfClass":9.99,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"LAMPERT MARK N","reportingCik":"0001233840","personType":"IN","sharesOwned":13630601,"percentOfClass":9.99,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-018848","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Vivo Opportunity Fund Holdings, L.P.","reportingCik":null,"personType":"PN","sharesOwned":29126906,"percentOfClass":9.99,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":"0001055947","personType":"IA,PN","sharesOwned":13630601,"percentOfClass":9.99,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-018848","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Vivo Opportunity Cayman, LLC","reportingCik":null,"personType":"OO","sharesOwned":2942094,"percentOfClass":9.99,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"BVF INC/IL","reportingCik":"0001056807","personType":"CO","sharesOwned":13630601,"percentOfClass":9.99,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":"0001803809","personType":"OO","sharesOwned":13140690,"percentOfClass":9.6,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"BVF I GP LLC","reportingCik":"0001803805","personType":"OO","sharesOwned":10113585,"percentOfClass":7.4,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":"0000918923","personType":"PN","sharesOwned":10113585,"percentOfClass":7.4,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":"0001102444","personType":"PN","sharesOwned":3027105,"percentOfClass":2.2,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"BVF II GP LLC","reportingCik":"0001803806","personType":"OO","sharesOwned":3027105,"percentOfClass":2.2,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":"0001660683","personType":"PN","sharesOwned":427629,"percentOfClass":0.3,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"BVF Partners OS Ltd.","reportingCik":"0001660684","personType":"CO","sharesOwned":427629,"percentOfClass":0.3,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000531","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-12","reportingPerson":"R. Thorvald Nagel","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-018443","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Guy Levy","reportingCik":null,"personType":"IN","sharesOwned":6792000,"percentOfClass":5.5,"filedAt":"2026-02-19","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-018443","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Soleus Capital Master Fund, L.P.","reportingCik":null,"personType":"FI","sharesOwned":6792000,"percentOfClass":5.5,"filedAt":"2026-02-19","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-018443","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Soleus Capital Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6792000,"percentOfClass":5.5,"filedAt":"2026-02-19","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-018443","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Soleus Capital Group, LLC","reportingCik":null,"personType":"OO","sharesOwned":6792000,"percentOfClass":5.5,"filedAt":"2026-02-19","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-018443","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Soleus Capital, LLC","reportingCik":null,"personType":"OO","sharesOwned":6792000,"percentOfClass":5.5,"filedAt":"2026-02-19","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-26-018443","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Soleus GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":6792000,"percentOfClass":5.5,"filedAt":"2026-02-19","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-26-001176","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Alyeska Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":7500000,"percentOfClass":6.24,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-26-001176","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Anand Parekh","reportingCik":null,"personType":"IN","sharesOwned":7500000,"percentOfClass":6.24,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-26-001176","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Alyeska Investment Group, L.P.","reportingCik":null,"personType":"IA","sharesOwned":7500000,"percentOfClass":6.24,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000467","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Zweiman Ari","reportingCik":null,"personType":"IN","sharesOwned":7500000,"percentOfClass":5.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000467","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"683 CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"IA","sharesOwned":7500000,"percentOfClass":5.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000921895-26-000467","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"683 CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":7500000,"percentOfClass":5.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-015336","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":10378406,"percentOfClass":8.22,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-015336","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":10378406,"percentOfClass":8.22,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001104659-26-015336","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":10378406,"percentOfClass":8.22,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001716774-26-000009","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Aberdeen Group plc","reportingCik":null,"personType":"HC","sharesOwned":8243941,"percentOfClass":6.85,"filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001716774-26-000009","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"abrdn Inc.","reportingCik":null,"personType":"CO,IA","sharesOwned":8243941,"percentOfClass":6.85,"filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001274173-25-000336","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-11-28","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":12016444,"percentOfClass":9.99,"filedAt":"2025-12-08","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-25-005186","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Alyeska Investment Group, L.P.","reportingCik":null,"personType":"IA","sharesOwned":11250000,"percentOfClass":9.35,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-25-005186","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Alyeska Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":11250000,"percentOfClass":9.35,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001172661-25-005186","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Anand Parekh","reportingCik":null,"personType":"IN","sharesOwned":11250000,"percentOfClass":9.35,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-25-006917","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Avidity Capital Partners Fund (GP) LP","reportingCik":null,"personType":"PN","sharesOwned":4699411,"percentOfClass":4.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-25-006917","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Michael Gregory","reportingCik":null,"personType":"HC,IN","sharesOwned":4699411,"percentOfClass":4.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-25-006917","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Avidity Partners Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":4699411,"percentOfClass":4.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-25-006917","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Avidity Partners Management (GP) LLC","reportingCik":null,"personType":"OO","sharesOwned":4699411,"percentOfClass":4.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0000919574-25-006917","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001280776","issuerName":"Immunic, Inc.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Avidity Capital Partners (GP) LLC","reportingCik":null,"personType":"OO","sharesOwned":4699411,"percentOfClass":4.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-25-107607","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Guy Levy","reportingCik":null,"personType":"IN","sharesOwned":1580007,"percentOfClass":1.6,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-25-107607","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Soleus GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":1580007,"percentOfClass":1.6,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-25-107607","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Soleus Capital Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1580007,"percentOfClass":1.6,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-25-107607","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Soleus PE GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":1060457,"percentOfClass":1.1,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-25-107607","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Soleus Private Equity Fund III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1060457,"percentOfClass":1.1,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-25-107607","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Soleus Private Equity GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":1060457,"percentOfClass":1.1,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-25-107607","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Soleus Capital, LLC","reportingCik":null,"personType":"OO","sharesOwned":519550,"percentOfClass":0.5,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-25-107607","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Soleus Capital Group, LLC","reportingCik":null,"personType":"OO","sharesOwned":519550,"percentOfClass":0.5,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/imux"},{"accessionNo":"0001213900-25-107607","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001280776","issuerName":"IMMUNIC, INC.","ticker":"IMUX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Soleus Capital Master Fund, L.P.","reportingCik":null,"personType":"FI","sharesOwned":519550,"percentOfClass":0.5,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/imux"}],"updatedAt":"2026-11-04T02:05:53.846Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/imux","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}